SureStart™ LactoB HN001™

An extensively studied probiotic, SureStart™ LactoB HN001™ supports immunity and health for mothers, infants and young children.

Lacticaseibacillus rhamnosus HN001*  

Suitable for:

  • Infant Nutrition

Certifications & Claims available:

  • Non-GMO (USA)

Disclaimer: While we try to represent product images accurately, the representation on your screen may be different from the actual product for various reasons. Religious/dietary status is indicative only and may vary between material numbers.

Supports infant immunity

Clinically tested to protect against eczema and reduce the risk of respiratory allergies such as hay fever and rhinitis.

Supports maternal wellbeing

May help to reduce the risk of gestational diabetes and postnatal depression.

High shelf life

Proprietary manufacturing techniques create more robust probiotics for NZMP powder applications.

China approved strain

One of only a few approved probiotics for use in foods for infants and young children in China.

Please Drag & Drop Background Image from Toggle Side Panel > Assets
Ingredient Features

This ingredient has the following features:

  • Freeze-dried powder
  • Specifications are available for powders or dry supplements
  • For maternal and paediatric applications
  • Flavourless
  • Vegetarian, Halal and Kosher
  • Non-GMO Project Verified
  • New Zealand origin

Boosts infant immunity

A strong immune system relies on well-balanced gut microbiome.  Probiotics are good bacteria that can help support the development and maintenance of a healthy immune system. 


Not all probiotics are proven to have the same benefits. Awareness of the specific benefits of particular probiotic strains and education on product efficacy is increasing. Fonterra probiotics are clinically tested to provide immune protection and other health benefits.  

The incidence of food allergies is growing

Prevalence of food allergies is a growing health concern, not only in Western countries but in rapidly developing countries.  In China, rising C-section rates, antibiotics abuse, and air pollution are placing babies at increased risk of allergies.


NZ Clinical Study: In a two-year clinical trial with 425 infants aged 0-24 months, supplementation with SureStart™ LactoB HN001™ demonstrated:

  • long term protection against eczema
  • reduced risk of respiratory allergies, an
  • extended beyond the treatment period and up to 11 years of age (ongoing follow-up)

Health during pregnancy is important for both mother and baby

The right nutrition is an important part of maintaining health and wellbeing.  Emerging evidence suggests SureStart™ LactoB HN001™ helps to reduce the risk of gestational diabetes and postnatal depression when taken during pregnancy and breastfeeding.


Gestational diabetes is a severe and neglected threat to maternal and child health

Gestational diabetes mellitus (GDM) occurs during pregnancy and can affect the health of mother and baby.


Complications include uncontrolled blood sugar levels, high blood pressure (preeclampsia) and a typically larger baby.  It is estimated that GDM affects 7-10% of all pregnancies worldwide.4 More than half of women with a history of GDM develop type 2 diabetes within 5-10 years post-birth.  

Depression during and after pregnancy is a common and serious condition

Depression is a mental illness affecting 322 million people worldwide, and as much as a third of the Chinese population5. Women are more vulnerable to depression, and this intensifies during and after pregnancy.


It is not uncommon for mothers to suffer from baby blues after having a baby.  Generally, this will last a day or two, whereas postnatal depression is a more serious condition, that not only impacts the mother (often causing stress and anxiety) but can reduce bonding with the baby. 

Globally, 10% of pregnant women and 13% of women post-birth experience a mental health problem.5 In China, 6-28% of women suffer from depression during pregnancy, while 10-28% suffer postnatal depression5.

NZ Clinical Study: A study with 423 pregnant women taking SureStart™ LactoB HN001™ from the second trimester until 6 months following birth demonstrated:

  • Reduced prevalence of Gestational Diabetes Mellitus (GDM) during pregnancy, and 
  • Significantly reduced symptoms of postnatal depression and anxiety.

SureStart™ is NZMP's brand for Paediatric Nutrition

  • [1] Tang 2018, The Epidemiology of Food Allergy in The Global Context.
  • [2] Gao Prevalence of GDM in mainland China: A systematic review and meta-analysis, 2019.
  • [3] International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017.
  • [4] Behboudi-Gandevani, The impact of diagnostic criteria for GDM on its prevalence: as systematic review and meta-analysis, 2019.
  • [5] The Effect of Maternal Depression on Infant Attachment: A Systematic Review Int. J. Environ. Res. Public Health 2020, 17, 2675; doi:10.3390/ijerph17082675.
Please Drag & Drop Background Image from Toggle Side Panel > Assets

The product should be stored in a freezer below –18°C. It is recommended that it is stored below –30°C. Product has a shelf life of 5 years when stored frozen.

Use immediately after opening. Do not re-seal in the sachet.

A Handling Protocol is available on request.

Let us share more with you

Login to myNZMP and unlock more valuable information about this ingredient

Please Drag & Drop Background Image from Toggle Side Panel > Assets
Important Disclaimer:  NZMP (and the Fonterra Group) makes no representations or warranties in respect of the information contained on the NZMP website or in this document, including representations or warranties (express or implied) concerning fitness for purpose or appropriateness (including whether such information can be used in compliance with any applicable jurisdiction) in relation to the use in connection with the marketing, promotion and sale of any third party products. Without limiting the foregoing, any use of, or reliance on, the information contained on the NZMP website or in this document is not the responsibility of NZMP or the Fonterra Group.

This information is designed to give a brief overview of the nature and characteristics of our products as at the date of preparation. It does not constitute representations or warranties as to such characteristics, the functionality or potential applications of our products. You must assure yourself of these matters having regard to our detailed product specifications, your specific circumstances and market requirements.

* In April 2020 the Lactobacillus genus was reclassified, resulting in a name change of our probiotic from Lactobacillus rhamnosus HN001 to Lacticaseibacillus rhamnosus HN001. There is no change to the abbreviated scientific notation L.rhamnosus HN001. Additional information can be found here

Please Drag & Drop Background Image from Toggle Side Panel > Assets

How can we help?

Receive the latest NZMP news, insights & updates direct to your inbox